OXA-204 Carbapenemase in Clinical Isolate of Pseudomonas guariconensis, Tunisia

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-05-15 DOI:10.3201/eid3106.250131

Nadia Jaidane, Wejdene Mansour, Lamia Tilouche, Pierre Châtre, Pauline François, Agnese Lupo, Saoussen Oueslati, Aymeric Jacquemin, Ali Lazzem, Sonia Karaborni, Laetitia Du Fraysseix, Yomna Ben Lamine, Nidhal Mahdhi, Abdelhalim Trabelsi, Jean-Yves Madec, Marisa Haenni, Thierry Naas

引用次数: 0

Abstract

We report an OXA-204–producing Pseudomonas guariconensis clinical isolate in, Tunisia, proving the spread of OXA-48 variants beyond Enterobacterales. The bla_OXA-204 gene was carried on a 119-kb chromosomally integrated plasmid fragment, along with multiple additional resistance genes. Surveillance, diagnostic tools, and antimicrobial drug access are needed to mitigate spread of carbapenem-resistant pathogens.

查看原文本刊更多论文

瓜里康假单胞菌临床分离株OXA-204碳青霉烯酶的研究

我们报告了在突尼斯产生oxa -204的guariconpseudomonas临床分离物，证明OXA-48变体在肠杆菌之外的传播。blaOXA-204基因位于一个119kb的染色体整合质粒片段上，同时携带多个抗性基因。需要监测、诊断工具和获得抗微生物药物，以减轻碳青霉烯耐药病原体的传播。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.